Enhancing Inflammation as an Adjuvant to Neovascular AMD Therapy.
Andrew D
AD
Dick
D000818:Animals; D042783:Endothelial Cells / Q000473:pathology*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D020382:Interleukin-18 / Q000008:administration & dosage*; D008268:Macular Degeneration / Q000188:drug therapy*; D015861:Retinal Neovascularization / Q000188:drug therapy*
D020382:Interleukin-18